Suppr超能文献

新型冠状病毒肺炎危重症患者的管理:我们所学到的与我们所采取的措施

Management of Critically Ill Patients with COVID-19: What We Learned and What We Do.

作者信息

Mahmoodpoor Ata, Shadvar Kamran, Ghamari Ali Akbar, Mohammadzadeh Lameh Mojtaba, Asghari Ardebili Roghayeh, Hamidi Masood, Soleimanpour Hassan

机构信息

Department of Anesthesiology and Critical Care Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Emergency Medicine Research Team, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Anesth Pain Med. 2020 Jun 10;10(3):e104900. doi: 10.5812/aapm.104900. eCollection 2020 Jun.

Abstract

There are many unknown questions and puzzle pieces that should describe the clinical course of COVID-19 and its complications, especially ARDS. We provide the initial immediate surge response to allow every patient in need of an ICU bed to receive one. Till our knowledge is improved, the most important intervention in the treatment of critically ill patients with COVID-19 seems to be the level of standard care and appropriate and early diagnosis and treatment. It seems that each center should have its protocol on the management of critically ill COVID-19 patients regarding prevention, diagnosis, and treatment. This treatment should now be performed regardless of the reason which lies behind the pathophysiology of this disease, which is yet unknown. In this report, we share our experience in the management of critically ill COVID-19 patients during the 2 months in our intensive care unit.

摘要

仍有许多未知问题和拼图碎片有待揭示,以描述新冠病毒疾病(COVID-19)的临床病程及其并发症,尤其是急性呼吸窘迫综合征(ARDS)。我们迅速做出初步应急反应,确保每一位需要重症监护床位的患者都能得到一张床位。在我们的认知得到提升之前,对于重症COVID-19患者的治疗,最重要的干预措施似乎是标准护理水平以及恰当且早期的诊断与治疗。似乎每个中心都应该制定关于重症COVID-19患者预防、诊断和治疗的管理方案。目前,无论该疾病尚未明确的病理生理学背后的原因是什么,都应进行这种治疗。在本报告中,我们分享在重症监护病房对重症COVID-19患者进行为期两个月管理的经验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87ae/7472789/c0479dad0579/aapm-10-3-104900-i001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验